News About: Pharm. Industry
LG releases new influenza test kit
LG Life Sciences says it has recently launched a new influenza A (H1N1) real-time RT-PCT kit which can detect multiple different pathogens in one single run based on protocols recommended by international health autho...
Pharmaceutical wholesalers to threaten action
As three leading wholesalers announced a plan to sever relations with Zeullig Korea, local wholesalers are threatening to take firm action unless multinational companies implement proper measures.
“The local wholes...
Bukwang to start preclinical trial for new VEGF inhibitor
Bukwang Pharm said on September 28 it will commence animal experiments for apatinib mesylate, a novel Vascular Endothelial Growth Factor (VEGF) inhibitor and complete the tests in the first half of next year.
To th...
Multinationals expressing discontent over Korea’s drug price reform
The Korean government’s Drug Price Reform plan would limit Korean patients’ access to newly-developed drugs which might cure them, according to a report released by the Korean-based Pharmaceutical Industry Association...
US FDA OKs clinical trial on stem cell
CJ Cheil Jedang says the U.S. Food and Drug Administration has allowed its U.S. partner Neuralstem Inc. to start an early-stage human trial of its spinal cord stem cells in Lou Gehrig's disease, a fatal neuromuscular ...
Concerns growing over Korea’s drug price reform
A new wave of price cuts for drugs is speculated to be imminent in Korea, which has stirred up concerns among pharmaceutical firms, multinational and domestic alike.
So far the details of the nation’s drug price re...
Green Cross releases nasal spray influenza vaccine
Green Cross Corp. says it has launched Flu Mist, the first and only nasal spray flu vaccine.
Developed by the US-based MedImmune Inc., FluMist is a live attenuated influenza virus vaccine indicated for active immun...
Ildong to market Niaspanor in Korea
Ildong Pharm and Abbott Korea has recently announced that the two companies have signed an agreement to let Ildong Pharm market Niaspanor (nicotinic acid) as an exclusive basis here, while Abbott Korea retains its lic...
Bayer Healthcare seek price cut to boost Levitra sales
Bayer Healthcare says it will reduce the price of Levitra 10 mg by 36 percent from next month, as part of its efforts to boost Levitra sales and have patients get a wider access to erectile dysfunction (ED) medicine.
...
“Right” price for domestic generic drugs is ongoing topics of debate
One of the things drug makers are famous for is their world of rebates, money given to hospitals and other medical institutions in exchange for a secure distribution channel.
Earlier, the Fair Trade Commission slap...
